Search Result "Par 1"
Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists
Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 1 Issue: 1 Year: 2003 Page: 1-11
Author(s): Steven M. Seiler, Michael S. Bernatowicz
Investigation of Thrombin Activity with PAR 1-based Fluorogenic Peptides
Journal: Protein & Peptide Letters
Volume: 20 Issue: 10 Year: 2013 Page: 1129-1135
Author(s): Saulo Martins Vieira,Flavia Garcia dos Reis,Reinaldo Geraldo,Denis Luis da Silva Dutra,Luiz Juliano,Maria Aparecida Julianod,Julio Alberto Mignaco,Russolina Benedeta Zingali
Thrombin Receptor Antagonists, Recent Advances in PAR-1 Antagonist Development
Journal: Current Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2002 Page: 1229-1250
Author(s): M. Anderluh, M. Sollner Dolenc
Discovery of Potent Peptide-Mimetic Antagonists for the Human Thrombin Receptor, Protease-Activated Receptor-1 (PAR-1)
Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 1 Issue: 1 Year: 2003 Page: 13-36
Author(s): Bruce E. Maryanoff, Han-Cheng Zhang, Patricia Andrade-Gordon, Claudia K. Derian
Agonists and Antagonists of Protease Activated Receptors (PARs)
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2006 Page: 243-265
Author(s): Grant D. Barry, Giang T. Le, David P. Fairlie
Activated Protein C and Acute Kidney Injury: Selective Targeting of PAR-1
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 1212-1226
Author(s): Akanksha Gupta, Mark D. Williams, William L. Macias, Bruce A. Molitoris, Brian W. Grinnell
The Human Pseudoautosomal Region (PAR): Origin, Function and Future
Journal: Current Genomics
Volume: 8 Issue: 2 Year: 2007 Page: 129-136
Author(s): A. Helena Mangs, Brian J. Morris
Protease-Activated Receptors (PARs) as Therapeutic Targets: Development of Agonists / Antagonists and Modulation of Gastrointestinal Functions
Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1 Issue: 4 Year: 2004 Page: 287-296
Author(s): Fumiko Sekiguchi, Atsufumi Kawabata
Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Journal: Current Drug Targets
Volume: 7 Issue: 5 Year: 2006 Page: 629-637
Author(s): B. A. De Campo, P. J. Henry
Par-4 for Molecular Therapy of Prostate Cancer
Journal: Current Drug Targets
Volume: 4 Issue: 3 Year: 2003 Page: 223-230
Author(s): James Butler, Vivek M. Rangnekar